White Paper

Preparing a BLA Submission Team

The functions, the sequencing, and the document control behind a biologics submission that stays on schedule.

15 pagesRegulatory affairs leaders and submission program managers

Overview

A BLA is a document control problem wearing a science costume. The science is usually settled months before filing. What slips is authoring capacity, review cycles, and the publishing work nobody scoped because it did not look like work.

The paper covers how to structure a submission team across regulatory, medical writing, CMC, and publishing, and the review cadence that keeps modules moving in parallel instead of one after another. It is aimed at a first or second filing, where there is no institutional memory to fall back on.

What you will learn

  • Scope authoring and review capacity against your target filing date
  • Give modules clear owners so reviews can run in parallel
  • Set document control practices that survive a late data change
  • Plan for agency questions without holding the whole team on standby
  • Decide what stays in-house and what comes in as contract support
  • Keep publishing off the critical path
Written forRegulatory affairs leaders and submission program managers
Topics
  • Regulatory Affairs
  • Pharmaceutical and Biotechnology

How Viltis helps

Related services

The practices in this paper map to work our consultants deliver directly. If you would rather have it done than read about it, start here.

Talk it through with a consultant

Bring us the program you are running and we will tell you what we would do, whether or not you need our people.